L'Oréal S.A. (ETR:LOR)
Germany · Delayed Price · Currency is EUR | Market Cap | 237.68B +25.9% |
| Revenue (ttm) | 45.35B +3.5% |
| Net Income | 6.31B +3.0% |
| EPS | 11.78 +3.2% |
| Shares Out | n/a |
| PE Ratio | 37.93 |
| Forward PE | 29.84 |
| Dividend | 7.20 (1.61%) |
| Ex-Dividend Date | Apr 29, 2026 |
| Volume | 593 |
| Open | 451.20 |
| Previous Close | 446.95 |
| Day's Range | 445.80 - 451.20 |
| 52-Week Range | 340.00 - 454.20 |
| Beta | 0.85 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 11, 2027 |
About L'Oréal
L'Oréal S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men in Europe, North America, North Asia, South Asia Pacific, the Middle East, North Africa, Sub-Saharan Africa, and Latin America. It operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty. The company offers skincare, make-up, hair colourant, haircare, perfume, and hygiene products. It provides its products under the L’Oréal Paris, Garnier, Maybelline New York, NYX Professional Makeup, Stylenanda, ... [Read more]
Financial Performance
In 2025, L'Oréal's revenue was 44.05 billion, an increase of 1.30% compared to the previous year's 43.49 billion. Earnings were 6.13 billion, a decrease of -4.39%.
Financial StatementsNews
The AI Summit New York 2026 Announces Keynote and Featured Speaker Lineup with Leaders from Google, L'Oréal and Dell Technologies
NEW YORK--(BUSINESS WIRE)-- #TheAISummit--The AI Summit New York today announced its 2026 keynote and featured speaker lineup, bringing together an influential cross-section of business executives and...
L’Oreal downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded L’Oreal (LRLCY) to Hold from Buy with a EUR 460 price target
L’Oreal upgraded to Buy from Hold at Erste Group
Erste Group analyst Stephan Lingnau upgraded L’Oreal (LRLCY) to Buy from Hold. Given accelerating revenue momentum, the firm expects the stock to continue to rise in price over the medium…
L’Oreal price target raised to EUR 480 from EUR 450 at RBC Capital
RBC Capital raised the firm’s price target on L’Oreal (LRLCY) to EUR 480 from EUR 450 and keeps an Outperform rating on the shares.
L’Oreal price target raised to EUR 470 from EUR 435 at Citi
Citi raised the firm’s price target on L’Oreal (LRLCY) to EUR 470 from EUR 435 and keeps a Buy rating on the shares.
L'Oreal shares bounce on third-quarter sales
Shares in L'Oreal rose 5% on Friday, hitting their highest in more than two years, after the French cosmetics giant reported third-quarter sales well ahead of expectations on strong demand for premi...
L'Oréal 9-Month Sales Rise 7.7%
(RTTNews) - L'Oréal SA (LRLCY.PK, OR.PA, LOR.DE) reported on Wednesday nine-month 2026 sales of €35.34 billion, up 7.7% year on year from €32.81 billion. Like-for-like growth was 6.9%, as the beauty g...
L'Oreal Eyes Profit Rise This Year as Sales Keep Growing
The company booked sales of $12.98 billion in the third quarter, a 7.2% increase, like-for-like, from the same period a year earlier.
L'Oréal Earnings Call Transcript: Q3 2026
Adjusted like-for-like growth accelerated to 7.7%, outperforming a beauty market up 5%; Europe and SAPMENA led. FY growth is expected to accelerate, with Q4 outperformance continuing at a more moderate pace.
L'Oréal Earnings release: Q3 2026
L'Oréal released its Q3 2026 earnings on October 22, 2026, summarizing the period's financial results.
L'Oreal Q3 sales beat forecasts as China demand picks up
French cosmetics group L'Oreal beat third-quarter sales forecasts on Thursday, boosted by demand for luxury perfumes, skincare and hair products, particularly in China and emerging markets.
L’Oreal reports Q3 revenue EUR 11.56B, like-for-like sales up 7.7% adjusted
Nicolas Hieronimus, CEO, said “L’Oreal (LRLCY) delivered an exceptional third quarter as adjusted like-for-like growth accelerated to +7.7% The global beauty market, once again, proved its resilience ...
L’Oreal reports 9 month sales EUR 35.33B, adjusted LFL sales up 6.9%
12:02 EDT L’Oreal (LRLCY) reports 9 month sales EUR 35.33B, adjusted LFL sales up 6.9%
Focus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Swiss skincare firm Galderma , Brazilian cosmetics group Natura and beauty giant L'Oreal are testing treatments for consumers worried about facial sagging and volume loss, looking to capitalise on a g...
Top 3 CAC 40 stocks to watch this week: Hermes, Essilor, and L'Oreal
The CAC 40 Index has tried to recover over the past few days, rising from this month's low of 7,682 points to 7,956 points today. Even so, it remains 9.10% below its highest level this year.
L'Oréal Taps Advisers to Explore Unloading Chemical-Related Liabilities
The cosmetics company's U.S. subsidiary is working with Weil Gotshal and Ducera to address talc-related lawsuits.
L'Oreal taps advisers to explore unloading chemical-related liabilities, WSJ reports
L'Oreal has engaged restructuring advisers to explore options for mounting US legal liabilities stemming from its use of talc and other chemical ingredients in some of its cosmetic products, the...
L'Oréal Cuts Customer Service Time 64% With AI
A L'Oréal adviser who needed to issue a customer a discount code once clicked through about 15 screens over 10 minutes. Now the adviser types a prompt, and artificial intelligence generates the code i...
L'Oréal Slides: Corporate presentation
L'Oréal has posted slides in relation to its latest quarterly earnings report, which was published on September 25, 2026.
L'Oreal steals French stock market crown from LVMH
Cosmetics group L'Oreal became France's most valuable listed company on Tuesday, surpassing Louis Vuitton owner LVMH as high-end luxury companies remain under pressure after years of slowing sa...
L’Oreal sued by Arizona for allegedly hiding cancer risk, Reuters says
L’Oreal (LRLCY) and its U.S. subsidiary have been sued by Arizona Attorney General Kristin Mayes, alleging the company hid evidence that its hair relaxer products could cause cancer in women,…
Arizona accuses L'Oreal of concealing cancer risks linked to hair relaxers
Arizona has sued L'Oreal SA , alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer in women, as it faces thousands of similar lawsuits from users and their fa...
L'Oréal Transcript: Barclays 19th Annual Global Consumer Conference
The conference introduced luxury, leisure, and retail to its agenda, with record participation. Strong H1 growth was driven by innovation, premiumization, and e-commerce, with standout performance in SAPMENA and China. Strategic focus remains on R&I, AI, M&A, and operational efficiencies.
L'Oréal Slides: Barclays 19th Annual Global Consumer Conference
L'Oréal has posted slides in relation to its latest quarterly earnings report, which was published on September 8, 2026.
L’Oreal upgraded to Outperform from Neutral at BNP Paribas
BNP Paribas analyst Jeff Stent upgraded L’Oreal (LRLCY) to Outperform from Neutral with a EUR 460 price target